Our findings from cancer xenograft models in mice and analysis of 34 normal tissues and cohorts of patient tumors, support CDCP1 as theranostic target to select cancer patients for CDCP1-directed therapies including ADCs. The gene discussed is CDCP1; the disease is cancer.